Abstract The coronavirus disease (COVID-19) caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has been declared a pandemic. Global research updates …

As the global COVID-19 pandemic evolves, our knowledge of the respiratory and non-
respiratory symptoms continues to grow. One such symptom, anosmia, may be a neurologic …

Severe acute respiratory syndrome (SARS) coronavirus‑2 (SARS‑CoV‑2) enters into human
host cells via mechanisms facilitated mostly by angiotensin‑converting enzyme 2 (ACE2) …

Abstract Coronavirus disease 2019 (COVID-19), a disease caused by the novel
betacoronavirus (SARS-CoV-2), has become a global pandemic threat. The potential …

The ongoing SARS-CoV-2 pandemic has proven to be challenging, in both clinical and
pathological terms. The viral tropism for angiotensinconverting enzyme 2 (ACE-2) receptor …

Decreased smell function is related to brain health, future mortality, and quality of life. Most
people inflicted with the SARS-CoV-2 virus evidence some measurable smell dysfunction …

SARS-CoV-2 patients show a highly variable disease course, ranging from asymptomatic
infections to critical illness and death. Most of the fatalities occur in the older patient …

Neurological complications have emerged as a significant cause of morbidity and mortality
in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized …

Neurological manifestations are frequently reported in the COVID-19 patients.
Neuromechanism of SARS-CoV-2 remains to be elucidated. In this study, we explored the …

Since the outbreak with novel corona virus in December 2019, a myriad of different
neurological manifestations in patients with COVID-19 infection have been reported. We …